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ABSTRACT: Studies on DNA−ligand interactions in the
cellular environment are problematic due to the lack of
suitable biophysical tools. To address this need, we
developed an in-cell NMR-based approach for monitoring
DNA−ligand interactions inside the nuclei of living
human cells. Our method relies on the acquisition of
NMR data from cells electroporated with preformed
DNA−ligand complexes. The impact of the intracellular
environment on the integrity of the complexes is assessed
based on in-cell NMR signals from unbound and ligand-
bound forms of a given DNA target. This technique was
tested on complexes of two model DNA fragments and
four ligands, namely, a representative DNA minor-groove
binder (netropsin) and ligands binding DNA base-pairing
defects (naphthalenophanes). In the latter case, we
demonstrate that two of the three in vitro-validated
ligands retain their ability to form stable interactions with
their model target DNA in cellulo, whereas the third one
loses this ability due to oﬀ-target interactions with
genomic DNA and cellular metabolites. Collectively, our
data suggest that direct evaluation of the behavior of drug-
like molecules in the intracellular environment provides
important insights into the development of DNA-binding
ligands with desirable biological activity and minimal side
eﬀects resulting from oﬀ-target binding.
DNA is an important target for drug design anddevelopment.1 Thus far, the development of DNA-
binding ligands has relied on data from in vitro biophysical
assays, in vivo or in cellulo biological assays, or in silico
structure-based DNA-targeting approaches. While biological
assays are indispensable for evaluating the biological eﬀects of
ligands, their principal disadvantage is the diﬃculty in
connecting the ligand-induced biological eﬀects to the direct
action of the ligand on its putative DNA target. In contrast,
both in vitro and in silico approaches are based on the
quantitative characterization of a simple two-component
(DNA−ligand) system under non-native conditions. They
allow characterization of the DNA−ligand complex in terms of
either the structure or quantitative parameters such as the
thermodynamic stability of the complex and the kinetics of its
formation.2−10 Notably, both in vitro and in silico approaches
provide information on DNA−ligand interactions in the
absence of the cellular environment. As a consequence, ligand
properties determined under these conditions do not
automatically reﬂect the eﬃcacy that the ligands display in
vivo, where the presence of alternative targets and various
environmental factors can inﬂuence the formation and stability
of DNA−ligand complexes. Undoubtedly, the development of
novel tools allowing direct evaluation of drug−target
interactions under complex conditions in living cells is of
general interest. Here, we elaborate on the recently introduced
electroporation concept devised for proteins11 and nucleic
acids12 and extend this approach to characterizing DNA−
ligand interactions in the nuclei of living human cells.
The application of in-cell NMR spectroscopy for investigat-
ing DNA−ligand interactions was tested using two model
systems comprising the complexes formed between (i) a 24-nt
DNA hairpin (MH-DNA) and netropsin, a polyamide ligand
representative of minor-groove DNA binders,13−15 and (ii) an
11-bp DNA duplex containing a T·T mismatch (TT-DNA)
and a set of three substituted naphthalenophanes 1−3, which
are representative of drugs targeting DNA base-pairing defects
(Figure 1).16,17 These models were chosen because, beyond
their potential therapeutic importance,15,16 the NMR signals of
their ligand-bound and unbound DNA targets are clearly
distinct, making them well suited for a proof-of-principle
demonstration of the in-cell NMR approach. First, we evaluated
the eﬃcacy of electroporation-based delivery of the NMR
substrate. Notably, two-step delivery of a ligand and its DNA
target to cells via two sequential electroporation procedures
resulted in high cell mortality and/or DNA leakage from cells
independent of the order of component delivery (i.e., DNA
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and ligand ) (Figure S1A−C). In contrast, the delivery of
complexes preformed in the electroporation (EC) buﬀer
proved to be highly eﬀective (Figure S1D): The complexes
were introduced into more than 92% of cells at concentrations
suﬃcient for their detection by NMR (Figures 2 and S2).
Importantly, among the cells transfected with the complexes
(i.e., those contributing to the in-cell NMR signals), over 98%
remained viable after the time required for the acquisition of
NMR spectra (Figure S2).
Moreover, confocal microscopy conﬁrmed that the delivered
DNA was localized in the nuclei (Figures 2 and S2), and a
time-resolved membrane leakage experiment and the com-
parable line widths between the in vitro and in-cell NMR
spectra indicated that this DNA was freely tumbling (Figures
S3 and S4). Most importantly, the imino region of the NMR
spectrum of a suspension of nontransfected cells showed no
signals (Figures 2 and S5, Note S1), whereas NMR spectra of
suspensions of cells transfected with DNA−ligand complexes
displayed signals originating from the introduced DNA
(Figures 2 and S2). The concentration of transfected
complexes in the in-cell NMR samples was estimated as 10−
15 μM (Figure S5C). Notably, in all cases, DNA leakage from
the cells was negligible, as demonstrated by the imino region of
the NMR spectra of the extracellular ﬂuid collected from the
samples after the acquisition of in-cell NMR spectra (Figures 2
and S2).
The in-cell NMR spectra showed well-resolved signal
patterns, which were compared with the in vitro NMR spectra
of unbound DNA and DNA−ligand complexes. For the MH-
DNA:netropsin, TT-DNA:1, and TT-DNA:2 complexes, their
in-cell NMR spectra corresponded to a superposition of the
spectra of the ligand-bound and unbound DNA substrates
(Figures 2, 3, and S2). However, for the TT-DNA:3 system,
the in-cell NMR spectrum closely resembled that of the
unbound DNA target (Figures 3, S2, and S6). Overall, the in-
cell NMR data for the TT-DNA:ligand system suggested that,
in contrast to DNA−ligand complexes under in vitro
conditions, complexes in the presence of intracellular factors
dissociated to an extent that was ligand dependent. To assess
whether the diﬀerences in the dissociation level between the
TT-DNA complexes of the three naphthalenophanes could be
a consequence of their diﬀerent eﬃciencies of delivery into
cells or whether the in-cell NMR spectra instead reﬂected real
diﬀerences in the capacity of the individual ligands to bind TT-
DNA in the cellular environment, we employed three separate
approaches. First, a mock electroporation experiment on the
preformed TT-DNA:ligand complexes dissolved in EC buﬀer
was performed: The application of high-voltage pulses
(emulating the setup used for electroporation) did not aﬀect
the integrity of the individual complexes (Figure S7). Then, we
delivered the DNA−ligand complexes into isolated intact
nuclei while omitting the electroporation step. Notably, the
NMR spectra of the complexes demonstrated only minor
dissociation of the TT-DNA:1 complex; however, moderate
and dramatic dissociation was observed in the nuclei
containing TT-DNA:2 and TT-DNA:3 (Figure 3). The
pattern of imino signals in the NMR spectrum of the TT-
DNA:3 system in intact nuclei was essentially identical to that
of the in-cell NMR spectrum of ligand-free TT-DNA (Figure
3 and S6). These observations suggest that nuclear
components are potential competitors for ligands 2 and,
particularly, 3. To elaborate on this hypothesis, we acquired
NMR spectra of TT-DNA:ligand complexes in the presence of
calf thymus (ct) DNA to emulate the inﬂuence of genomic
DNA. The presence of ctDNA resulted in a shift in TT-DNA
from its ligand-bound form toward the unbound form, which
was particularly pronounced for the TT-DNA:3 complex
(Figure S8). These results suggest that dissociation of the
complex observed in the intact cells and intact cell nuclei can,
at least partly, be attributed to ligand binding to alternative
Figure 1. Schematic representations of the DNA targets and DNA-binding ligands used in the present study. (A) Netropsin and its model target,
hairpin-based DNA (MH-DNA). (B) Three substituted naphthalenophanes and their model target, T·T mismatch-containing DNA (TT-DNA).
Ligand binding sites are indicated in red.
Figure 2. Double-staining (PI/FAM) FCM analysis (A) and confocal
microscopy images (B) of cells cotransfected with the (FAM)-MH-
DNA:netropsin (1:1) complex. In panel (A), the percentages of viable
nontransfected cells, viable MH-DNA containing cells, dead/
compromised nontransfected cells, and dead/compromised trans-
fected cells are indicated in the bottom-left, bottom-right, top-left, and
top-right quadrants, respectively. In panel (B), the green color marks
the localization of (FAM)-MH-DNA, while the blue color marks cell
nuclei stained with Hoechst 33342. (C) Deconvoluted imino regions
of 1D 1H NMR spectra of MH-DNA in vitro and the 1:1 MH-
DNA:netropsin complex in vitro and in cells. NMR spectra of
extracellular ﬂuid taken from the sample after in-cell NMR spectral
acquisition and of nontransfected cells (cellular background) are
shown in gray. The vertical green and blue dashed lines mark imino
signals speciﬁc to the unbound and ligand-bound forms of MH-DNA,
respectively.
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sites in the genomic DNA, which is in line with the properties
of naphthalenophanes previously observed in vitro. In fact,
while the three ligands share similar physicochemical proper-
ties, ligand 3, which has a diﬀerent topology, nonspeciﬁcally
binds to double-stranded DNA much more strongly than do
ligands 1 and 2.16,18 Finally, we recorded NMR spectra of
individual complexes dissolved in cytosolic lysate and in a
solution of cellular metabolites, corresponding to the low-
molecular-weight cellular fraction prepared from the acetoni-
trile extract of nontransfected cells (Supporting Information,
Material and Methods). The acquired spectra of the cytosolic
lysate were dominated by signals speciﬁc to the formed
complexes (Figure 3); however, low-intensity imino signals
from unbound TT-DNA were also present, suggesting that
some components in the cytosolic environment slightly impact
the integrity of individual complexes.
Remarkably, the most pronounced changes in the spectral
patterns of all the complexes were observed in the presence of
cellular metabolites (Figure 3). While the spectra of the TT-
DNA:1 and TT-DNA:2 complexes in the metabolite solution
showed signals of comparable intensity from both unbound
and ligand-bound TT-DNA, the corresponding NMR spec-
trum of the TT-DNA:3 complex was dominated by signals
from unbound TT-DNA (Figure 3). The latter observation
suggests substantial dissociation of the TT-DNA:3 complex in
the presence of metabolites. The capacity of metabolites to act
as oﬀ-targets for ligands was subsequently conﬁrmed using an
NMR titration experiment , in which the metabolic solution
was titrated with individual ligands at various concentrations
(50 and 100 μM). Ligand- and concentration-dependent
changes in the positions and intensities of NMR signals from
several metabolites, such as ATP, cAMP, GMP, and fumarate,
were indicative of ligand−metabolite binding (Figure S9).
Accordingly, in vitro NMR spectra of 1:1 mixtures of ligands
with these metabolites conﬁrmed their capacity to interact with
the ligands (Figure S10). Altogether, the ex vivo NMR
measurements showed that the presence of both metabolic
and nuclear components might promote the dissociation of
TT-DNA:ligand complexes; however, the extent of this eﬀect
was ligand dependent.
To summarize, we demonstrated that DNA−ligand
complexes can be monitored in the nuclei of living human
cells using NMR spectroscopy. Analysis of in-cell NMR spectra
using the spectral ﬁngerprint concept19 reveals whetherand
to what extentthe intracellular components and the
environment of living cells inﬂuence the stability of these
complexes. For the TT-DNA:ligand model systems, we
identiﬁed the nature of the cellular components susceptible
to act as oﬀ-targets and disrupt the DNA−ligand complexes
and conﬁrmed that the dissociation of individual complexes
evidenced by in-cell NMR spectra was primarily due to the
inﬂuence of these factors and not an artifact of the
electroporation process.
The in-cell NMR measurement can be considered a
sophisticated competitive binding experiment performed
under physiological conditions, where the model target DNA
inserted into cells in excess competes for the ligand with
everything else in the cell and where the stabilities of
DNA:ligand complexes are aﬀected by nonspeciﬁc intracellular
environmental factors such as crowding, water activity,
dielectric permittivity, or local ionic concentration. These
conditions are speciﬁc to the intracellular environment of
intact cells: They are not replicated in cellular lysates/fractions,
and they cannot be reliably emulated in vitro, as illustrated by
the conﬂicting results obtained from measurements of the TT-
DNA:1, 2, and 3 complexes in the presence of either PEG200
or Ficoll 70, most commonly used mimics of molecular
crowding20−23 and conditions of reduced dielectric permittivity
in the intracellular space (Figure S11).24−26 In that respect, the
in-cell NMR experiments are particularly suited for validation
of ligands that, after being identiﬁed as promising candidates
by in vitro screening assays, maintain or even reinforce their
ability to bind to the target DNA in cells, thereby justifying
their further development.
As with other currently available approaches for high-
resolution structural analysis of DNA, the presented method
provides only information on the behavior of short DNA
fragments. In other words, the in-cell NMR data do not reﬂect
the inﬂuence of chromatin context or packing. However, the
fact that DNA-binding ligands generally do not act on closed
chromatin but rather during processes involving its open state,
Figure 3. Deconvoluted imino regions of 1D 1H NMR spectra of TT-DNA in EC buﬀer and the TT-DNA:ligand complexes in-cell, ex vivo (intact
nuclei/cytosolic lysate/metabolic solution), and in EC buﬀer (in vitro). The vertical green and blue dashed lines mark imino signals speciﬁc to the
unbound and ligand bound forms of TT-DNA, respectively. For controls of the in-cell NMR measurements, see Figure S2.
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such as transcription and replication, provides justiﬁcation for
the use of our system as a model replicating the eﬀect of DNA-
targeting ligands in vivo. Furthermore, the presented approach
can be directly extended to RNA-based targets. The approach
is also invariant of isotopic or chemical labeling of the sample
and can be directly adapted for analysis of RNA/DNA:ligand
complexes using in-cell EPR27−29 and in-cell single particle
FRET.30
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